Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Aniline | HCID 6115 | — |
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | Benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphate | HCID 151348 | — |
| Reactant | HCID 67700610 | HCID 67700610 | — |
| Catalyst | 4-(Dimethylamino)pyridine | HCID 14284 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 67699525 | HCID 67699525 | — |
Reaction Steps
A solution of 95 mg of [1-(Isopropyl-phenyl-carbamoylmethyl)-3-methyl-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl]-butyric acid, prepared as in Intermediate 34, 75.1 mg of BOP, 24.2 mg of HOBT, 21 mg of DMAP and 16.4 mg of aniline in DMF (0.5 ml) is stirred at RT overnight. The reaction mixture is diluted with 50 mL of ethyl acetate and washed with 1N aqueous sodium hydroxide solution (×2), water, 0.5N hydrochloric acid (×2), water and brine. The organic extract is dried over MgSO4 and concentrated in vacuo to afford the crude product. Purification by silica gel flash column chromatography (10% MeOH in methylene chloride) gave 45 mg of the title compound as a clear glass: 1H NMR (300 MHz, CDCl3) δ8.6 (s, 1H), 6.8-7.7 (m, 19H), 5.11 (sept, 1H, J=7.1), 4.59 (d, 1H, J=8.9), 3.71 (d, 1H, J=8.9,), 2.09 (m, 2H), 1.81 (m, 2H), 1.59 (s, 3H), 1.4 (m, 2H), 1.04 (dd, 6H, J=7.1); low resolution MS (FAB) m/e 603 (MH+).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05859007 |
|---|
| Source dataset | uspto-grants-1999_01 |
|---|
| ORD ID | ord-539f49e6a7124fba90efb8f83559e232 |
|---|
| Source note | uspto-grants-1999_01 |
|---|